Barre verticale Université de Lausanne - Unisciences
Séparateur Annuaire Séparateur Actualités Séparateur Aide Séparateur Login
Langues:  fr | en
Photo ambiance
UNIL > Unisciences >
de à
Données actuelles

Hans Acha-Orbea

Coordonnées Curriculum Recherches Enseignements Publications
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être modifiées via MyUnil



Margaroli C., Oberle S., Lavanchy C., Scherer S., Rosa M., Strasser A., Pellegrini M., Zehn D., Acha-Orbea H., Ehirchiou D., Role of proapoptotic BH3-only proteins in Listeria monocytogenes infection. European Journal of Immunology 46(6), pp. 1427-1437, 2016. [DOI] [Web of Science] [Pubmed] ok

Pigni M., Ashok D., Acha-Orbea H., Derivation and Utilization of Functional CD8(+) Dendritic Cell Lines. Methods in Molecular Biology 1423, pp. 39-49, 2016. [DOI] [Web of Science] [Pubmed] ok

Thelemann C., Haller S., Blyszczuk P., Kania G., Rosa M., Eriksson U., Rotman S., Reith W., Acha-Orbea H., Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis. European Journal of Immunology 46(3), pp. 656-664, 2016. [DOI] [Web of Science] [Pubmed] ok


Cohen S.B., Smith N.L., McDougal C., Pepper M., Shah S., Yap G.S., Acha-Orbea H., Jiang A., Clausen B.E., Rudd B.D. et al., β-Catenin Signaling Drives Differentiation and Proinflammatory Function of IRF8-Dependent Dendritic Cells. Journal of Immunology 194(1), pp. 210-222, 2015. [DOI] [Web of Science] [Pubmed]

Grosjean F., Nasi S., Schneider P., Chobaz V., Liu A., Mordasini V., Moullec K., Vezzoni P., Lavanchy C., Busso N. et al., Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. Plos One 10(8), p. e0133917, 2015. [DOI] [Web of Science] [Pubmed] ok

Széles L., Meissner F., Dunand-Sauthier I., Thelemann C., Hersch M., Singovski S., Haller S., Gobet F., Fuertes Marraco S.A., Mann M. et al., TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State. Journal of Immunology 195(3), pp. 1025-1033, 2015. [DOI] [Web of Science] [Pubmed] ok

Vremec D., Hansen J., Strasser A., Acha-Orbea H., Zhan Y., O'Keeffe M., Shortman K., Maintaining dendritic cell viability in culture. Molecular Immunology 63(2), pp. 264-267, 2015. [DOI] [Web of Science] [Pubmed]


Ashok D., Acha-Orbea H., Timing is everything: dendritic cell subsets in murine Leishmania infection. Trends in Parasitology 30(10), pp. 499-507, 2014. [DOI] [Web of Science] [Pubmed]

Ashok D., Schuster S., Ronet C., Rosa M., Mack V., Lavanchy C., Marraco S.F., Fasel N., Murphy K.M., Tacchini-Cottier F. et al., Cross-presenting dendritic cells are required for control of Leishmania major infection. European Journal of Immunology 44(5), pp. 1422-1432, 2014. [DOI] [Web of Science] [Pubmed]

Benasciutti E., Mariani E., Oliva L., Scolari M., Perilli E., Barras E., Milan E., Orfanelli U., Fazzalari N.L., Campana L. et al., MHC Class II Transactivator Is an In Vivo Regulator of Osteoclast Differentiation and Bone Homeostasis Co-opted From Adaptive Immunity. Journal of Bone and Mineral Research 29(2), pp. 290-303, 2014. [DOI] [Web of Science] [Pubmed]

Duval A., Fuertes Marraco S.A., Schwitter D., Leuenberger L., Acha-Orbea H., Large T Antigen-Specific Cytotoxic T Cells Protect Against Dendritic Cell Tumors through Perforin-Mediated Mechanisms Independent of CD4 T Cell Help. Frontiers in Immunology 5, p. 338, 2014. [Document] [DOI] [Web of Science] [Pubmed]

Seguín-Estévez Q., Dunand-Sauthier I., Lemeille S., Iseli C., Ibberson M., Ioannidis V., Schmid C.D., Rousseau P., Barras E., Geinoz A. et al., Extensive remodeling of DC function by rapid maturation-induced transcriptional silencing. Nucleic Acids Research 42(15), pp. 9641-9655, 2014. [Document] [DOI] [Web of Science] [Pubmed]

Thelemann C., Eren R.O., Coutaz M., Brasseit J., Bouzourene H., Rosa M., Duval A., Lavanchy C., Mack V., Mueller C. et al., Interferon-γ Induces Expression of MHC Class II on Intestinal Epithelial Cells and Protects Mice from Colitis. PLoS One 9(1), p. e86844, 2014. [Document] [DOI] [Web of Science] [Pubmed]

von Burg N., Chappaz S., Baerenwaldt A., Horvath E., Bose Dasgupta S., Ashok D., Pieters J., Tacchini-Cottier F., Rolink A., Acha-Orbea H. et al., Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses. Proceedings of the National Academy of Sciences of the United States of America 111(35), pp. 12835-12840, 2014. [DOI] [Web of Science] [Pubmed]


Duraes F.V., Thelemann C., Sarter K., Acha-Orbea H., Hugues S., Reith W., Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: facts and fiction. Tissue Antigens 82(1), pp. 1-15, 2013. [DOI] [Web of Science] [Pubmed]

Kypriotou M., Rivero D., Haller S., Mariotto A., Huber M., Acha-Orbea H., Werner S., Hohl D., Activin a inhibits antigen-induced allergy in murine epicutaneous sensitization. Frontiers in Immunology 4(246), pp. 1-10, 2013. [Document] [DOI] [Web of Science] [Pubmed]


Bär E., Gladiator A., Bastidas S., Roschitzki B., Acha-Orbea H., Oxenius A., LeibundGut-Landmann S., A novel Th cell epitope of Candida albicans mediates protection from fungal infection. Journal of Immunology 188(11), pp. 5636-5643, 2012. [DOI] [Web of Science] [Pubmed]

Chevrier S., Genton C., Malissen B., Malissen M., Acha-Orbea H., Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Frontiers in Immunology 3, p. 27, 2012. [Document] [DOI] [Web of Science] [Pubmed]

Ciarlo E., Lugrin J., dos Santos Pinheiro I., Le Roy D., Moulan N., Yamamoto H., Acha-Orbea H., Calandra T., Auwerx J., Roger T., Impact of Sirtuin 2 knockout on innate immune responses. In: European Congress of Immunology. Immunology 137(Suppl. 1),, p. 271, 2012. [Web of Science]

Fuertes Marraco S.A., Grosjean F., Duval A., Rosa M., Lavanchy C., Ashok D., Haller S., Otten L.A., Steiner Q.G., Descombes P. et al., Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research. Frontiers in Immunology 3, p. 331, 2012. [Document] [DOI] [Pubmed]


Cheng J.M., Chee S.H., Knight D.A., Acha-Orbea H., Hermans I.F., Timmer M.S., Stocker B.L., An improved synthesis of dansylated α-galactosylceramide and its use as a fluorescent probe for the monitoring of glycolipid uptake by cells. Carbohydrate Research 346(7), pp. 914-926, 2011. [DOI] [Web of Science] [Pubmed]

Dunand-Sauthier I., Santiago-Raber M.L., Capponi L., Vejnar C.E., Schaad O., Irla M., Seguín-Estévez Q., Descombes P., Zdobnov E.M., Acha-Orbea H. et al., Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood 117(17), pp. 4490-4500, 2011. [DOI] [Web of Science] [Pubmed]

Fuertes Marraco S.A., Scott C.L., Bouillet P., Ives A., Masina S., Vremec D., Jansen E.S., O'Reilly L.A., Schneider P., Fasel N. et al., Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS One 6(6), p. e20189, 2011. [Document] [DOI] [Web of Science] [Pubmed]

Ives A., Ronet C., Prevel F., Ruzzante G., Fuertes-Marraco S., Schutz F., Zangger H., Revaz-Breton M., Lye L.F., Hickerson S.M. et al., Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331(6018), pp. 775-778, 2011. [Document] [DOI] [Web of Science] [Pubmed]

Siegert S., Huang H.Y., Yang C.Y., Scarpellino L., Carrie L., Essex S., Nelson P.J., Heikenwalder M., Acha-Orbea H., Buckley C.D. et al., Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide. PLoS One 6(11), p. e27618, 2011. [Document] [DOI] [Web of Science] [Pubmed]

Xu Y., Schnorrer P., Proietto A., Kowalski G., Febbraio M.A., Acha-Orbea H., Dickins R.A., Villadangos J.A., IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression. Journal of Immunology 186(6), pp. 3666-3673, 2011. [DOI] [Web of Science] [Pubmed]


Ramelli G., Fuertes S., Narayan S., Busso N., Acha-Orbea H., So A., Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo. Immunology 129(1), pp. 20-27, 2010. [DOI] [Web of Science] [Pubmed] ok


Chevrier S., Genton C., Kallies A., Karnowski A., Otten L.A., Malissen B., Malissen M., Botto M., Corcoran L.M., Nutt S.L. et al., CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proceedings of the National Academy of Sciences of the United States of America 106(10), pp. 3895-3900, 2009. [DOI] [Web of Science] [Pubmed] ok

Schmutz S., Bosco N., Chappaz S., Boyman O., Acha-Orbea H., Ceredig R., Rolink A.G., Finke D., Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells. Journal of immunology 183(4), pp. 2217-2221, 2009. [DOI] [Web of Science] [Pubmed] ok


Bossen C., Cachero T.G., Tardivel A., Ingold K., Willen L., Dobles M., Scott M.L., Maquelin A., Belnoue E., Siegrist C.A. et al., TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111(3), pp. 1004-1012, 2008. [DOI] [Web of Science] [Pubmed] ok

Steiner Q. G., Otten L. A., Hicks M. J., Kaya G., Grosjean F., Saeuberli E., Lavanchy C., Beermann F., McClain K. L., Acha-Orbea H., In vivo transformation of mouse conventional CD8alpha+ dendritic cells leads to progressive multisystem histiocytosis. Blood 111(4), pp. 2073-2082, 2008. [DOI] [Web of Science] [Pubmed] ok

Wang Y., Kissenpfennig A., Mingueneau M., Richelme S., Perrin P., Chevrier S., Genton C., Lucas B., DiSanto J.P., Acha-Orbea H. et al., Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. Journal of Immunology 180(3), pp. 1565-1575, 2008. [Web of Science] [Pubmed]


Acha-Orbea H., Shakhov A.N., Finke D., Immune response to MMTV infection. Frontiers in Bioscience 12, pp. 1594-1609, 2007. [DOI] [Web of Science] [Pubmed]

Link A., Vogt T.K., Favre S., Britschgi M.R., Acha-Orbea H., Hinz B., Cyster J.G., Luther S.A., Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nature Immunology 8(11), pp. 1255-1265, 2007. [DOI] [Web of Science] [Pubmed]

Luther S.A., Serre K., Cunningham A.F., Khan M., Acha-Orbea H., MacLennan I.C., Toellner K.M., Recirculating CD4 memory T cells mount rapid secondary responses without major contributions from follicular CD4 effectors and B cells. European Journal of Immunology 37(6), pp. 1476-1484, 2007. [DOI] [Web of Science] [Pubmed]

Meier D., Bornmann C., Chappaz S., Schmutz S., Otten L.A., Ceredig R., Acha-Orbea H., Finke D., Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 26(5), pp. 643-654, 2007. [DOI] [Web of Science] [Pubmed]


Genton C., Wang Y., Izui S., Malissen B., Delsol G., Fournié G.J., Malissen M., Acha-Orbea H., The Th2 lymphoproliferation developing in LatY136F mutant mice triggers polyclonal B cell activation and systemic autoimmunity. Journal of Immunology 177(4), pp. 2285-2293, 2006. [Web of Science] [Pubmed]

Gumy A., Aseffa A., Rachinel N., Breton M., Otten L., Tacchini-Cottier F., Röcken M., Doyen N., Acha-Orbea H., Locksley R.M. et al., LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major. European Journal of Immunology 36(6), pp. 1465-1473, 2006. [DOI] [Web of Science] [Pubmed] ok

Otten L.A., Leibundgut-Landmann S., Huarte J., Kos-Braun I.C., Lavanchy C., Barras E., Borisch B., Steimle V., Acha-Orbea H., Reith W., Revisiting the specificity of the MHC class II transactivator CIITA in vivo. European Journal of Immunology 36(6), pp. 1548-1558, 2006. [DOI] [Web of Science] [Pubmed]


Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., Qiang F., Gorelik L., Kalled S.L., Acha-Orbea H. et al., Identification of proteoglycans as the APRIL-specific binding partners. Journal of Experimental Medicine 201(9), pp. 1375-1383, 2005. [Document] [DOI] [Web of Science] [Pubmed]


Didierlaurent A., Ramirez J.C., Gherardi M., Zimmerli S.C., Graf M., Orbea H.A., Pantaleo G., Wagner R., Esteban M., Kraehenbuhl J.P. et al., Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses. Vaccine 22(25-26), pp. 3395-403, 2004. [DOI] [Web of Science] [Pubmed] ok

LeibundGut-Landmann S., Waldburger J.M., Krawczyk M., Otten L.A., Suter T., Fontana A., Acha-Orbea H., Reith W., Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. European Journal of Immunology 34(6), pp. 1513-1525, 2004. [DOI] [Web of Science] [Pubmed]

LeibundGut-Landmann S., Waldburger J.M., Reis e Sousa C., Acha-Orbea H., Reith W., MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nature Immunology 5(9), pp. 899-908, 2004. [DOI] [Web of Science] [Pubmed]


Finke D., Luther S.A., Acha-Orbea H., The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development. Proceedings of the National Academy of Sciences of the United States of America 100(1), pp. 199-204, 2003. [DOI] [Web of Science] [Pubmed]

Mpandi M., Otten L.A., Lavanchy C., Acha-Orbea H., Finke D., Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle. Journal of virology 77(17), pp. 9369-77, 2003. [DOI] [Web of Science] [Pubmed] ok

Otten L.A., Tacchini-Cottier F., Lohoff M., Annunziato F., Cosmi L., Scarpellino L., Louis J., Steimle V., Reith W., Acha-Orbea H., Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. Journal of Immunology 170(3), pp. 1150-1157, 2003. [Web of Science] [Pubmed]

Ramirez J.C., Finke D., Esteban M., Kraehenbuhl J.P., Acha-Orbea H., Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration. Archives of virology 148(5), pp. 827-39, 2003. [DOI] [Web of Science] [Pubmed] ok

Waldburger J.M., Rossi S., Hollander G.A., Rodewald H.R., Reith W., Acha-Orbea H., Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells. Blood 101(9), pp. 3550-9, 2003. [DOI] [Web of Science] [Pubmed] ok


Balmelli C., Demotz S., Acha-Orbea H., De Grandi P., Nardelli-Haefliger D., Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles. Journal of Virology 76(24), pp. 12596-12602, 2002. [DOI] [Web of Science] [Pubmed] ok

Cunningham A.F., Fallon P.G., Khan M., Vacheron S., Acha-Orbea H., MacLennan I.C., McKenzie A.N., Toellner K.M., Th2 activities induced during virgin T cell priming in the absence of IL-4, IL-13, and B cells. Journal of Immunology 169(6), pp. 2900-2906, 2002. [Web of Science] [Pubmed]

Finke D., Acha-Orbea H., Mattis A., Lipp M., Kraehenbuhl J., CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 17(3), pp. 363-373, 2002. [DOI] [Web of Science] [Pubmed]

Lens S.M., Kataoka T., Fortner K.A., Tinel A., Ferrero I., MacDonald R.H., Hahne M., Beermann F., Attinger A., Orbea H.A. et al., The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Molecular and Cellular Biology 22(15), pp. 5419-5433, 2002. [DOI] [Web of Science] [Pubmed] ok

Otten L.A., Finke D., Acha-Orbea H., Can MMTV exploit TLR4? Trends in Microbiology 10(7), pp. 303-306, 2002. [DOI] [Web of Science] [Pubmed]

Vacheron S., Luther S.A., Acha-Orbea H., Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus. Journal of Immunology 168(7), pp. 3470-3476, 2002. [Web of Science] [Pubmed]

Wirth S., Bille F., Koenig S., Wehrli N., Miconnet I., Lévy F., Diggelmann H., Romero P., Acha-Orbea H., Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T-lymphocyte responses against a melanoma tumor antigen. International Journal of Cancer 99(2), pp. 201-206, 2002. [DOI] [Pubmed] ok

Wirth S., Vessaz A., Krummenacher C., Baribaud F., Acha-Orbea H., Diggelmann H., Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule. Journal of Virology 76(21), pp. 11172-11175, 2002. [DOI] [Web of Science] [Pubmed] ok


Attinger A., MacDonald H.R., Acha-Orbea H., Lymphoid environment limits superantigen and antigen-induced T cell proliferation at high precursor frequency. European Journal of Immunology 31(3), pp. 884-893, 2001. [DOI] [Web of Science] [Pubmed] ok

Bachmann M.F., Gallimore A., Jones E., Ecabert B., Acha-Orbea H., Kopf M., Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. European Journal of Immunology 31(2), pp. 450-458, 2001. [DOI] [Web of Science] [Pubmed] ok

Baribaud F., Wirth S., Maillard I., Valsesia S., Acha-Orbea H., Diggelmann H., Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains. Journal of Virology 75(16), pp. 7453-7461, 2001. [DOI] [Web of Science] [Pubmed] ok

Finke D., Acha-Orbea H., Differential migration of in vivo primed B and T lymphocytes to lymphoid and non-lymphoid organs. European Journal of Immunology 31(9), pp. 2603-2611, 2001. [DOI] [Web of Science] [Pubmed] ok

Finke D., Baribaud F., Diggelmann H., Acha-Orbea H., Extrafollicular plasmablast B cells play a key role in carrying retroviral infection to peripheral organs. Journal of Immunology 166(10), pp. 6266-6275, 2001. [Web of Science] [Pubmed]

Klein M.A., Kaeser P.S., Schwarz P., Weyd H., Xenarios I., Zinkernagel R.M., Carroll M.C., Verbeek J.S., Botto M., Walport M.J. et al., Complement facilitates early prion pathogenesis. Nature Medicine 7(4), pp. 488-492, 2001. [DOI] [Web of Science] [Pubmed] ok

Maillard I., Launois P., Himmelrich H., Acha-Orbea H., Diggelmann H., Locksley R.M., Louis J.A., Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice. European Journal of Immunology 31(4), pp. 1288-1296, 2001. [Web of Science] [Pubmed]

Waldburger J.M., Suter T., Fontana A., Acha-Orbea H., Reith W., Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. Journal of Experimental Medicine 194(4), pp. 393-406, 2001. [Document] [DOI] [Web of Science] [Pubmed]

Wehrli N., Legler D.F., Finke D., Toellner K.M., Loetscher P., Baggiolini M., MacLennan I.C., Acha-Orbea H., Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. European Journal of Immunology 31(2), pp. 609-616, 2001. [DOI] [Web of Science] [Pubmed] ok


Attinger A., Acha-Orbea H., MacDonald H.R., Cutting edge: cell autonomous rather than environmental factors control bacterial superantigen-induced T cell anergy in vivo. Journal of Immunology 165(3), pp. 1171-1174, 2000. [Web of Science] [Pubmed] ok

Aude-Garcia C., Attinger A., Housset D., MacDonald H.R., Acha-Orbea H., Marche P.N., Jouvin-Marche E., Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen. Molecular Immunology 37(16), pp. 1005-1012, 2000. [Web of Science] [Pubmed] ok

Chapuis A.G., Paolo Rizzardi G., D'Agostino C., Attinger A., Knabenhans C., Fleury S., Acha-Orbea H., Pantaleo G., Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nature Medicine 6(7), pp. 762-768, 2000. [DOI] [Web of Science] [Pubmed] ok

Wittelsberger A., Keller M., Scarpellino L., Patiny L., Acha-Orbea H., Mutter M., Pseudoprolines: Targeting a cis Conformation in a Mimetic of the gp120 V3 Loop of HIV-1 We are grateful to Dipl.-Biol. Raymond Jacquet for helpful advice. This work was supported by the Swiss National Science Foundation. Angewandte Chemie 39(6), pp. 1111-1115, 2000. [DOI] [Web of Science] [Pubmed]


Acha-Orbea H., Finke D., Attinger A., Schmid S., Wehrli N., Vacheron S., Xenarios I., Scarpellino L., Toellner K.M., MacLennan I.C. et al., Interplays between mouse mammary tumor virus and the cellular and humoral immune response. Immunological Reviews 168, pp. 287-303, 1999. [DOI] [Web of Science] [Pubmed]

Ardavín C., Martín P., Ferrero I., Azcoitia I., Anjuère F., Diggelmann H., Luthi F., Luther S., Acha-Orbea H., B cell response after MMTV infection: extrafollicular plasmablasts represent the main infected population and can transmit viral infection. Journal of Immunology 162(5), pp. 2538-2545, 1999. [Web of Science] [Pubmed]

Astori M., Finke D., Karapetian O., Acha-Orbea H., Development of T-B cell collaboration in neonatal mice. International Immunology 11(3), pp. 445-451, 1999. [DOI] [Web of Science] [Pubmed]

Baribaud F., Maillard I., Vacheron S., Brocker T., Diggelmann H., Acha-Orbea H., Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen. Journal of Virology 73(10), pp. 8403-8410, 1999. [Web of Science] [Pubmed] ok

Baribaud F., Shaw A.V., Scarpellino L., Diggelmann H., Acha-Orbea H., Preferential binding of mouse mammary tumor virus to B lymphocytes. Journal of Virology 73(9), pp. 7899-7902, 1999. [Web of Science] [Pubmed] ok

Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H. et al., BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. Journal of Experimental Medicine 189(11), pp. 1747-1756, 1999. [Document] [DOI] [Web of Science] [Pubmed]

Velin D., Fotopoulos G., Kraehenbuhl J.P., Acha-Orbea H., Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues. Journal of Virology 73(2), pp. 1729-1733, 1999. [Web of Science] [Pubmed] ok


Finke D., Mortezavi L., Acha-Orbea H., Preactivation of B lymphocytes does not enhance mouse mammary tumor virus infection. Journal of Virology 72(9), pp. 7688-7691, 1998. [Web of Science] [Pubmed] ok

Maillard I., Launois P., Xenarios I., Louis J.A., Acha-Orbea H., Diggelmann H., Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor. Journal of Virology 72(4), pp. 2638-2646, 1998. [Web of Science] [Pubmed]

Maillard I., Xenarios I., Diggelmann H., Orbea H.A., Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen. European Journal of Immunology 28(10), pp. 3075-3085, 1998. [DOI] [Web of Science] [Pubmed] ok

Toellner K.M., Luther S.A., Sze D.M., Choy R.K., Taylor D.R., MacLennan I.C., Acha-Orbea H., T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. Journal of Experimental Medicine 187(8), pp. 1193-1204, 1998. [DOI] [Web of Science] [Pubmed]


Acha-Orbea H., Retrovirus-host interactions. The mouse mammary tumor virus model. Medicina 57(Suppl 2), pp. 43-52, 1997. [Web of Science] [Pubmed]

Acha-Orbea H., The role of superantigens in resistance to retroviral infection. Trends in Microbiology 5(10), p. 385, 1997. [DOI] [Web of Science] [Pubmed]

Ardavin C., Luthi F., Andersson M., Scarpellino L., Martin P., Diggelmann H., Acha-Orbea H., Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model. Journal of Virology 71(10), pp. 7295-7299, 1997. [Web of Science] [Pubmed] ok

Launois P., Maillard I., Pingel S., Swihart K.G., Xénarios I., Acha-Orbea H., Diggelmann H., Locksley R.M., MacDonald H.R., Louis J.A., IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6(5), pp. 541-549, 1997. [DOI] [Web of Science] [Pubmed] ok

Luther S.A., Acha-Orbea H., Mouse mammary tumor virus: immunological interplays between virus and host. Advances in Immunology 65, pp. 139-243, 1997. [DOI] [Web of Science] [Pubmed]

Luther S.A., Gulbranson-Judge A., Acha-Orbea H., MacLennan I.C., B cell response and histology of a retroviral infection in vivo. Annals of the New York Academy of Sciences 815, pp. 465-466, 1997. [DOI] [Web of Science] [Pubmed]

Luther S.A., Gulbranson-Judge A., Acha-Orbea H., MacLennan I.C., Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. Journal of Experimental Medicine 185(3), pp. 551-562, 1997. [DOI] [Web of Science] [Pubmed]

Luther S.A., Maillard I., Luthi F., Scarpellino L., Diggelmann H., Acha-Orbea H., Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells. Journal of Immunology 159(6), pp. 2807-2814, 1997. [Web of Science] [Pubmed]

MacLennan I.C., Gulbranson-Judge A., Toellner K.M., Casamayor-Palleja M., Chan E., Sze D.M., Luther S.A., Orbea H.A., The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunological reviews 156, pp. 53-66, 1997. [DOI] [Web of Science] [Pubmed] ok

Maillard I., Luthi F., Acha-Orbea H., Diggelmann H., Role of the immune response induced by superantigens in the pathogenesis of microbial infections. Parasitology 115 Suppl, pp. S67-S78, 1997. [DOI] [Web of Science] [Pubmed]

Vacheron S., Renno T., Acha-Orbea H., A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection. Journal of Virology 71(10), pp. 7289-7294, 1997. [Web of Science] [Pubmed] ok


Acha-Orbea H., Mouse mammary-tumor virus: the basics of an oncogenic retrovirus. Steiner Young Investigator Award Lecture 1995. International Journal of Cancer 66(3), pp. 285-286, 1996. [DOI] [Web of Science] [Pubmed] ok

Acha-Orbea H., Superantigens of mouse mammary tumour virus: implications for diabetes? Diabetes/Metabolism Reviews 12(2), pp. 111-119, 1996. [DOI] [Web of Science] [Pubmed]

Ardavín C., Waanders G., Ferrero I., Anjuère F., Acha-Orbea H., MacDonald H.R., Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells. Journal of Immunology 157(7), pp. 2789-2794, 1996. [Web of Science] [Pubmed] ok

Braun M.Y., Lowin B., French L., Acha-Orbea H., Tschopp J., Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. Journal of Experimental Medicine 183(2), pp. 657-661, 1996. [DOI] [Web of Science] [Pubmed]

Champagne E., Scarpellino L., Lane P., Acha-Orbea H., CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. European Journal of Immunology 26(7), pp. 1595-1602, 1996. [DOI] [Web of Science] [Pubmed]

Krummenacher C., Diggelmann H., Acha-Orbea H., In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen. Journal of Virology 70(5), pp. 3026-3031, 1996. [Web of Science] [Pubmed] ok

Luther S.A., Acha-Orbea H., Immune response to mouse mammary tumour virus. Current Opinion in Immunology 8(4), pp. 498-502, 1996. [DOI] [Web of Science] [Pubmed]

Maillard I., Erny K., Acha-Orbea H., Diggelmann H., A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. European Journal of Immunology 26(5), pp. 1000-1006, 1996. [DOI] [Web of Science] [Pubmed] ok

Renno T., Acha-Orbea H., Superantigens in autoimmune diseases: still more shades of gray. Immunological Reviews 154, pp. 175-191, 1996. [DOI] [Web of Science] [Pubmed]

ok : Revue avec comité de lecture

Transparent     Swiss University
Unicentre  -  CH-1015 Lausanne  -  Suisse  -  Tél. +41 21 692 11 11  -  Fax +41 21 692 20 15